Clinical Trial Update: Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing high-dose chemotherapy plus Rituximab versus CHOP plus Rituximab in high-risk follicular lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Azienda Ospedaliera San Giovanni Battista | Conditions: Follicular Lymphoma | Phase 3 | Status: UNKNOWN